SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2-independent mechanism
Abstract Evidence suggests that platelets may directly interact with SARS-CoV-2, raising the concern whether ACE2 receptor plays a role in this interaction. The current study showed that SARS-CoV-2 interacts with both platelets and megakaryocytes despite the limited efficiency. Abundance of the conv...
Main Authors: | Shu Shen, Jingyuan Zhang, Yaohui Fang, Sihong Lu, Jun Wu, Xin Zheng, Fei Deng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-04-01
|
Series: | Journal of Hematology & Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13045-021-01082-6 |
Similar Items
-
Phytochemicals as Potential Therapeutics for SARS-CoV-2–Induced Cardiovascular Complications: Thrombosis and Platelet Perspective
by: Samir K. Beura, et al.
Published: (2021-04-01) -
SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19
by: Si Zhang, et al.
Published: (2020-09-01) -
SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling
by: Thankamani Karthika, et al.
Published: (2021-07-01) -
Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins
by: Sai Priya Anand, et al.
Published: (2020-09-01) -
ACE2: the molecular doorway to SARS-CoV-2
by: Miriam Marlene Medina-Enríquez, et al.
Published: (2020-12-01)